Abstract
For the first time, we report the influence of vitamin D2 and vitamin D3 on genome-wide gene expression in whole blood from healthy women representing two ethnic groups, white European and South Asian. In this randomised placebo-controlled trial, participants were given daily physiological doses (15 µg) of either vitamin D2 or D3 for 12 weeks and changes in the transcriptome were compared relative to the transcriptome at baseline. While there was some overlap in the repertoire of differentially expressed genes after supplementation with each vitamin D source, most changes were specific to either vitamin D3 or vitamin D2, suggesting that each form of the vitamin may have different effects on human physiology. Notably, following vitamin D3 supplementation, the majority of changes in gene expression reflected a down-regulation in the activity of genes, many encoding components of the innate and adaptive immune systems. These are consistent with the emerging concept that vitamin D orchestrates a shift in the immune system towards a more tolerogenic status. Moreover, divergent changes were observed following supplementation with either vitamin D3 or vitamin D2 for gene expression associated with type 1 and type 2 interferon activity. This is particularly intriguing as interferons play a critical role in the innate response to infection and aberrant type 1 interferon signalling is implicated in severe COVID-19 disease. The observed differences in gene expression after supplementation with vitamin D2 compared with vitamin D3 warrant a more intensive investigation of the biological effects of the two forms of vitamin D on human physiology.
Significance statements This study suggests that the influence of vitamins D2 and D3 on human physiology may not be the same, as deduced from differences in gene expression within whole blood.
South Asian participants were found to respond differently to vitamin D supplementation at the transcriptome level from white Europeans.
The differentially expressed immune pathways identified in this study are consistent with vitamin D orchestrating a more tolerogenic immune status and this could be relevant in the context of the severity of immune response to viral infections such as Covid-19.
The potential relevance of this study to severe Covid-19 disease is highlighted by our observed enhancement of type 1 interferon signalling by vitamin D3, but not vitamin D2.
Competing Interest Statement
The authors have declared no competing interest.
Clinical Trial
ISRCTN23421591
Funding Statement
This work was funded by BBSRC (UK) DRINC award BB/I006192/1 to SLN and CPS, by a University of Brighton Innovation Seed Fund Award (to CPS). A philanthropic donation was made by Michael Chowen CBE DL and Maureen Chowen (to CPS). With the exception of the above awards, no authors received payments from a third party for any aspect of the submitted work
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This study received ethical approval from the South-East Coast (Surrey) National Health Service Research Ethics Committee (11/LO/0708) and the University of Surrey Ethics Committee (EC/2011/97/FHMS). All of the participants gave written informed consent in agreement with the Helsinki Declaration before commencing study activities.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Manuscript expanded by including a Gene Set Enrichment Analysis of the transcriptome data. This includes new sections in the Results, Discussion, Materials and Methods and figure legends sections, an additional main figure (Fig. 7), three additional supplementary figures (4, 5 and 6) and one new supplementary data file. This updated version now presents further analysis prompted by recent findings on the interferon signalling response in severe Covid-19 disease and our observations on the impact of vitamin D2 and vitamin D3 on expression of these interferon signalling pathways.
Data Availability
All details of participants and their metadata are archived in a previous publication (https://doi.org/10.3945/ajcn.116.138693) and the pertinent data for this publication also forms supplementary data files linked with this submission. The full transcriptome data sets have been deposited with the international repository ArrayExpress and allocated accession number: E-MTAB-8600
